116 related articles for article (PubMed ID: 8382471)
21. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
22. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
[TBL] [Abstract][Full Text] [Related]
23. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients.
Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
Nephron; 2000 Mar; 84(3):224-7. PubMed ID: 10720892
[TBL] [Abstract][Full Text] [Related]
24. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients.
Ohya M; Negi S; Sakaguchi T; Koiwa F; Ando R; Komatsu Y; Shinoda T; Inaguma D; Joki N; Yamaka T; Ikeda M; Shigematsu T
J Clin Endocrinol Metab; 2014 Oct; 99(10):3873-8. PubMed ID: 24937533
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive parathyroid hormone and in vitro inhibition of erythropoiesis by uremic serum in patients on continuous ambulatory peritoneal dialysis.
Pierratos A; Toor P; Ayiomamitis A; Oreopoulos D; Keating A
Am J Nephrol; 1986; 6(6):465-8. PubMed ID: 3565503
[TBL] [Abstract][Full Text] [Related]
26. Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests.
De Cristofaro V; Samà F; Pagliari B; Colturi C; Sidoti A; Masa A; Filippini M; Comelli M; Pedrini L
Clin Nephrol; 1998 Feb; 49(2):113-20. PubMed ID: 9524782
[TBL] [Abstract][Full Text] [Related]
27. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
[TBL] [Abstract][Full Text] [Related]
28. Effect of direction and rate of change of calcium on parathyroid hormone secretion in uraemia.
Cunningham J; Altmann P; Gleed JH; Butter KC; Marsh FP; O'Riordan JL
Nephrol Dial Transplant; 1989; 4(5):339-44. PubMed ID: 2505183
[TBL] [Abstract][Full Text] [Related]
29. Relationship between plasma level of parathyroid hormone and carboxymethyllysine in hemodialyzed patients--does it exist?
Kokot F; Schinzel R; Chudek J; Heidland A; Adamczak M; Ficek R; Wiecek A
Clin Nephrol; 2003 Jan; 59(1):31-4. PubMed ID: 12572928
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic disease in uremia and parathyroid hormone excess.
Avram RM; Iancu M
Nephron; 1982; 32(1):60-2. PubMed ID: 7177279
[TBL] [Abstract][Full Text] [Related]
31. Reversibility of experimental secondary hyperparathyroidism.
Lewin E; Wang W; Olgaard K
Kidney Int; 1997 Nov; 52(5):1232-41. PubMed ID: 9350646
[TBL] [Abstract][Full Text] [Related]
32. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
Meakins JL; Milne CA; Hollomby DJ; Goltzman D
Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
[TBL] [Abstract][Full Text] [Related]
33. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
Kazama JJ; Omori T; Ei I; Ei K; Oda M; Maruyama H; Narita I; Gejyo F; Shigematsu T; Fukagawa M
Clin Exp Nephrol; 2003 Jun; 7(2):144-9. PubMed ID: 14586733
[TBL] [Abstract][Full Text] [Related]
34. Gastric acid secretion, calcitonin and secondary hyperparathyroidism in uremic patients undergoing regular dialysis therapy (RDT).
Antonucci F; Vezzadini P; Cecchettin M; Bonora G; Adami A; Compiano U; Feder G
Int J Artif Organs; 1978 Nov; 1(6):260-5. PubMed ID: 738794
[TBL] [Abstract][Full Text] [Related]
35. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
[No Abstract] [Full Text] [Related]
36. The effect of cholecalciferol and calcitriol on biochemical bone markers in HIV type 1-infected males: results of a clinical trial.
Bang UC; Kolte L; Hitz M; Schierbeck LL; Nielsen SD; Benfield T; Jensen JE
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):658-64. PubMed ID: 23199009
[TBL] [Abstract][Full Text] [Related]
37. Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism.
Kotzmann H; Köller M; Abela C; Clodi M; Riedl M; Graninger W; Niederle B; Luger A
Eur J Clin Invest; 1998 May; 28(5):353-8. PubMed ID: 9650007
[TBL] [Abstract][Full Text] [Related]
38. Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ T lymphocytes in HIV-1-infected males.
Bang U; Kolte L; Hitz M; Dam Nielsen S; Schierbeck LL; Andersen O; Haugaard SB; Mathiesen L; Benfield T; Jensen JE
HIV Clin Trials; 2012; 13(3):162-70. PubMed ID: 22592096
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone is not an inhibitor of lipoprotein lipase activity.
Arnadottir M; Nilsson-Ehle P
Nephrol Dial Transplant; 1994; 9(11):1586-9. PubMed ID: 7870347
[TBL] [Abstract][Full Text] [Related]
40. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
Clin Nephrol; 1998 Oct; 50(4):236-46. PubMed ID: 9799069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
